Merck KGaA Will Invest EUR250 Million in New Swiss Facility

Date : 01/27/2020 @ 2:18PM
Source : Dow Jones News
Stock : Merck KGAA (MRK)
Quote : 92.6  3.1 (3.46%) @ 3:01PM

Merck KGaA Will Invest EUR250 Million in New Swiss Facility

Merck KGAA (XE:MRK)
Historical Stock Chart

3 Months : From Dec 2019 to Mar 2020

Click Here for more Merck KGAA Charts.
   By Mauro Orru 
 

Merck KGaA (MRK.XE) will invest 250 million euros ($275.5 million) to deliver a new facility in Switzerland for biotech development and manufacturing for clinical studies, the company said Monday.

The Germany pharmaceuticals and chemicals company said construction of the new facility in Corsier-sur-Vevey is expected to be completed in 2021 and enter service by the end of 2022.

"Our investment in this biotech-development facility in Switzerland is strongly related to the growth and progression of our health-care pipeline, and our confidence in its future potential," said Belen Garijo, member of the Merck executive board and CEO for health care.

Merck added that the new facility would consist of a building with 15,700 square meters of development space.

The facility will house roughly 250 employees.

 

Write to Mauro Orru at mauro.orru@wsj.com; @MauroOrru94

 

(END) Dow Jones Newswires

January 27, 2020 09:03 ET (14:03 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.


$
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.